Trial Details
COMPLETEDBasic Information
| Clinical ID | c4063 |
|---|---|
| Identifier | NCT01100684 |
| Trial Title | Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Diarrhea Predominant Irritable Bowel Syndrome |
| Interventions | DRUG: Asimadoline|DRUG: Placebo |
Participant Information
| Sponsor | Tioga Pharmaceuticals |
|---|---|
| City | Athens |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2010-05 |
|---|---|
| Primary Completion Date | 2013-06 |
| Completion Date | 2013-06 |